Tcw Group Inc Dr Reddys Laboratories LTD Transaction History

Tcw Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$35.77 - $40.57 $1.48 Million - $1.68 Million	-41,300 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$31.89 - $38.44 $548,508 - $661,168	-17,200 Reduced 29.4%	41,300 $1.56 Million
Q3 2018 Oct 30, 2018	BUY	$29.25 - $36.73 $11,700 - $14,691	400 Added 0.69%	58,500 $2.02 Million
Q2 2018 Aug 02, 2018	BUY	$28.49 - $35.06 $1.66 Million - $2.04 Million	58,100 New	58,100 $1.87 Million

237

23.8M

14.6K

2.8K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.42B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.